Moximed Welcomes Michael Mydra as Senior VP for Market Access
Moximed Welcomes Michael Mydra as Senior Vice President of Reimbursement
Moximed, a leader in innovative medical devices, has announced the addition of Michael Mydra to its team as the Senior Vice President of Reimbursement and Market Access. This appointment aims to reinforce the company’s commitment to enhancing care for individuals suffering from knee osteoarthritis (OA).
Michael Mydra's Expertise and Experience
Michael Mydra is recognized for his remarkable track record in achieving critical coding, coverage, and payment strategies for groundbreaking medical technologies. Chris Gleason, the President and CEO of Moximed, expressed enthusiasm about Michael joining the Moximed team, noting that his background in establishing five Category I CPT codes will be invaluable as the company seeks to broaden access to the MISHA Knee System.
Previous Roles Contributing to His Success
Before joining Moximed, Michael Mydra held a pivotal position as the Senior Vice President of Reimbursement and Market Access at PainTEQ, Inc. His extensive experience spans a variety of roles in reimbursement and market access across several well-regarded medical technology firms, including Sanarus Medical, Vertos Medical, SI-BONE, Boston Scientific, and Profound Medical.
A Vision for Expanding Access to Treatment
In reflecting on his new role, Michael expressed, "It is an honor to join the talented team at Moximed. The clinical evidence supporting the MISHA Knee System is robust and will continue to grow. I am eager to help expand access to this disruptive technology as we look to transform the lives of millions of people affected by knee osteoarthritis." His enthusiasm underscores the potential impact of Moximed’s advancements in OA treatment.
What is the MISHA Knee System?
The MISHA Knee System is designed specifically for patients suffering from medial knee OA who have not found relief through other treatments. Many of these individuals continue to endure significant pain, making daily activities cumbersome. This demographic often includes those who are not suitable for joint replacement surgery due to age or the absence of advanced OA. Total knee replacements are usually a last resort for patients with serious illness. Thus, the need for effective alternatives is paramount.
Understanding Osteoarthritis and Treatment Needs
Knee OA arises when the natural shock-absorbing structures of the joint—such as cartilage and meniscus—start failing. This deterioration results in chronic pain and limits individuals' daily activities. Many people dealing with mild to moderate OA are otherwise active and healthy, often unwilling to consider total knee replacement, which indicates advanced disease. Therefore, preserving knee function and facilitating a better quality of life remain high priorities for these patients.
How the MISHA Knee System Works
Research has shown that offloading painful osteoarthritic joints can alleviate discomfort and enhance function. The MISHA Knee System distinguishes itself as the first implantable shock absorber, designed to reduce stress on the knee joint with every step taken. This innovative approach allows users to experience pain relief and potentially postpone the need for more invasive procedures like joint replacement. Placed on the medial side of the knee, the system synchronizes with natural joint movements, diminishing peak forces on the knee by approximately 30% with each step.
Commitment to Quality and Safety
Moximed’s MISHA Knee System has received FDA clearance, affirming its safety and efficacy for users. This significant milestone highlights Moximed's dedication to advancing care standards for individuals suffering from knee OA through innovative solutions.
About Moximed
Headquartered in Fremont, California, Moximed’s innovative technology is the culmination of over ten years of clinical research and development. The MISHA Knee System represents the first implantable shock absorber targeting the treatment of medial compartment knee OA. Moximed is committed to improving the standard of care and enhancing the quality of life for millions of individuals battling knee pain associated with osteoarthritis.
Frequently Asked Questions
What role has Michael Mydra taken on at Moximed?
Michael Mydra has joined Moximed as Senior Vice President of Reimbursement and Market Access, focusing on expanding access to innovative treatments.
What is the MISHA Knee System designed for?
The MISHA Knee System is specifically developed for patients with medial knee OA who have not found relief through other treatments and who aren't ready for joint replacement.
How does the MISHA Knee System alleviate knee pain?
The MISHA Knee System acts as an implantable shock absorber, reducing weight on the knee joint with each step, thereby easing pain and improving function.
Is the MISHA Knee System FDA approved?
Yes, the MISHA Knee System has received FDA clearance, confirming its safety for patients with knee osteoarthritis.
Where is Moximed located?
Moximed is headquartered in Fremont, California, and is committed to advancing treatment options for knee osteoarthritis sufferers.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Transformational Growth: How Autodesk Stock Has Thrived
- Lawsuit Targets Lil Durk and Record Labels in Shooting Case
- Architect Securities Achieves FINRA Membership for Growth
- Experience a Magical Winter Wonderland at Fontainebleau Las Vegas
- Catholic Charities USA Mobilizes for Hurricane Milton Relief
- Hurricane Milton's Impact on Florida's Homeowners Insurance Market
- TC Energy Unveils Cash Tender Offers for Debt Securities
- Automotive Actuators Market Growth and Future Trends Analysis
- Important Legal Update for STMicroelectronics Shareholders
- Growing Asthma Treatment Market Approaches 32 Billion USD
Recent Articles
- Exciting Developments at SIMPPLE Ltd. in Australia and New Zealand
- Leadership Transition at Postmedia: A New Chapter Begins
- NRSInsights Reports Growth in Retail Same-Store Sales
- Kellie MacLeod Joins Worldwide Clinical Trials Leadership Team
- Sure Shot Rebranding: Transforming Alcohol Wellness Solutions
- UroGen Appoints Chris Degnan as CFO to Propel Growth
- SaverOne's New Partnership Opens Doors in Spain and Portugal
- Kynisca Appoints Markel Zubizarreta as Sporting Director
- Cloud ERP Market Growth Driven by AI Integration and Trends
- BIOTECanada Expands Leadership with New Board Appointments
- Lucent, Inc. Expands Technology Through Strategic Acquisition
- BTIG Strengthens Energy Investment Banking with New Hire
- Growth of Gold Trade and Its Unique Contributors
- Verisk's Upcoming Financial Results Announcement Overview
- Arda Therapeutics Announces $43M Funding for Revolutionary Therapies
- TRIMEDX Expands Leadership for Enhanced Service and Innovation
- Bausch + Lomb Financial Results Discussion Set for Late October
- Ouster Schedules Third Quarter 2024 Financial Results Call
- SeaStar Medical to Highlight Innovations in Upcoming Summit
- Rambus Set to Reveal 2024 Third Quarter Financial Insights
- SCOR Initiates Tender Offer for MRM's Complete Share Capital
- Take-Two Interactive Announces Q2 Fiscal Year 2025 Report
- Unit-Linked Insurance Market Growth Forecast to 2032
- Fastly Announces Q3 2024 Financial Results and Conference Call
- Clean Energy Fuels Corp. to Announce Q3 2024 Results Soon
- Unlocking the Potential of the Growing Cell Culture Market
- Zeta Global's Strategic Acquisition of LiveIntent for Growth
- Service Properties Trust Plans Q3 2024 Financial Call
- Poni Insurtech Partners With Global Care for Insurance Innovation
- Meta's Threads to Enhance User Engagement with Reels Sharing
- Pioneer Reports Strong Growth in Quarterly Revenue Forecast
- Microgrid Solutions by MCFI Transform Remote Alaskan Connectivity
- SunOpta's Dream Oatmilk Set to Light Up 6,700 New Stores
- Revitalizing Canada's AI Landscape for Future Success
- United Warehouse Partners with Starwarehouse for Solar Energy
- Building Trust in Rental Cars: What Customers Expect
- New Prostate Cancer Guidelines for South America Emphasize Care
- Strategic Acquisition: Industrial Threaded Products Expands Reach
- UbiRider Triumphs as Premier Public Transit Tech Solution
- Empowering Health in Communities Through Virtual Conference 2030
- Key Factors Behind TSMC's Recent Stock Surge
- SoFi Unveils Innovative Everyday and Essential Credit Cards
- Citi Analysts Boost Optimism for Major Cruise Stocks
- Discovering Advanced Investment Solutions Through Arta Finance
- United Warehouse Expands Green Initiatives with New Solar Deal
- Enhanced Radar Technology Revolutionizes Expeditionary Operations
- Analysts Optimistic About Netflix and Other Key Stocks
- Ovintiv's Stock Target Adjustment: What Investors Should Know
- MLTT Attracts Major Investment to Boost North American Table Tennis
- Michael Burry's Strategic Shift to Chinese Stocks Yields Results